- Details
- Description
Packaging Size:
1 × 1's
Strength:
100 mg/4 mL
Composition:
Pembrolizumab
Treatment:
Anti-Cancer / Oncology
Form:
Injection
Brand:
Pemomab
Quantity Unit:
Vial
Manufacturer:
Ziska Pharmaceuticals Limited
Pemomab (Pembrolizumab) is a monoclonal antibody and immune checkpoint inhibitor used in cancer immunotherapy. It works by blocking the PD-1 receptor, helping the immune system recognize and attack cancer cells. It is used to treat various cancers, including certain lung, melanoma, head and neck, kidney, bladder, and other solid tumors, depending on the specific indication and biomarker status. Pemomab is administered by intravenous infusion under medical supervision.
